Rusan Healthcare

Rusan Pharma is a fully integrated global pharmaceutical company specializing in the research, development, and manufacturing of products for addiction treatment and pain management. The company is a market leader in the de-addiction space, offering a comprehensive range of treatments for opioid, alcohol, and tobacco dependence, including buprenorphine and methadone formulations. Beyond addiction, Rusan focuses on specialized delivery systems such as transdermal patches and long-acting injectables for chronic pain and neurological disorders. Headquartered in Mumbai, India, the company operates state-of-the-art R&D centers and manufacturing facilities that comply with international regulatory standards like the UK MHRA and EU GMP.